|
|
Nexium - Newsfeeds
-
-
NATIONAL HARBOR, Md.--( BUSINESS WIRE )--AstraZeneca (NYSE: AZN) today announced results from PN400-304, a long-term safety study of VIMOVO™ (naproxen/esomeprazole magnesium) 500/20 mg delayed-release tablets in osteoarthritis patients requiring daily ...
-
-
VIMOVO, codeveloped by AstraZeneca and POZEN Inc. (POZN: News ), is a fixed-dose combination of enteric-coated naproxen, a pain-relieving NSAID, and immediate-release esomeprazole magnesium, an ulcer risk-reducing proton pump inhibitor, approved for the ...
-
-
Vimovo or naproxen/esomeprazole magnesium is a fixed-dose combination of enteric-coated naproxen, a pain-relieving NSAID, and immediate-release esomeprazole magnesium, an ulcer risk-reducing proton pump inhibitor. The FDA approved Vimovo in April 2010 and ...
-
-
Angelique Whitehurst, PhD, assistant professor of pharmacology and a member of UNC Lineberger Comprehensive Cancer Center, has been awarded one of 13 Innovative Research Grants from Stand Up to Cancer , the scientific partner of the American Association of ...
-
-
a proprietary fixed dose combination of the proton pump inhibitor esomeprazole magnesium with the naproxen in a single tablet for the management of pain and inflammation associated with conditions, such as osteoarthritis and rheumatoid arthritis in ...
-
-
The California Public Employees' Retirement System is negotiating a lucrative pharmacy benefits management contract with Caremark Rx Inc., a company being sued for defrauding the pension fund of tens of millions of dollars (Lifsher, 4/16). The Washington ...
-
-
Vimovo has already been approved for use in the United States. The drug is a combination of naproxen, a common painkiller, and esomeprazole magnesium, which is the active pharmaceutical ingredient in the heartburn drug Nexium. AstraZeneca shares are up 0.5 ...
-
-
The Wall Street Journal is reporting that Johnson & Johnson is in talks to buy medical device maker Synthes, of West Chester, Pennsylvania, for $20 billion. The WSJ describes talks as “fragile,” but if they go through, what will the deal mean for ...
-
-
The Only Heart attack and Cardiac Rehabilitation Program for a Healthy Heart Calgary , AB — Heart Fit Clinic is the only cardiac rehabilitation, maintenance and heart attack and stroke prevention program. We see people with heart disease or who are at ...
-
-
AstraZeneca’s ( AZN ) heartburn drug Nexium was the second-biggest brand with $6.3 billion in revenue last year. AstraZeneca has fought off patent challenges and has protection from generic rivals until at least 2014. Merck’s ( MRK ) Singulair faces ...
-
-
I’ve been writing a lot about how the pharmaceuticals business has moved away from marketing drugs for common illnesses, and toward selling more expensive medicines for rare diseases. For more evidence, look no further than Amgen ’s first quarter ...
-
-
An Ohio woman suffered bone deterioration and broken bones because of hidden risks with pharmaceutical giant AstraZeneca's acid reflux drug Nexium, The Gibson Law Firm alleges in a lawsuit filed today in Texas federal court. Filed in the U.S. District ...
-
-
HOUSTON — A woman has filed a lawsuit against a drug manufacturer because, she said, an acid reflux medication caused her bones to deteriorate and break. Ginny Begin, 58, from Ohio, filed the lawsuit against AstraZeneca in Houston on Tuesday. Begin ...
-
-
AstraZeneca, the U.K.'s second-biggest drug maker, confirmed that a number of its sites in Europe had been visited this week, mainly focusing on its top-seller heartburn drug, Nexium, also known as esomeprazole. "The Commission has reason to believe that ...
-
-
AstraZeneca said inspections at its premises concerned the ulcer drug Nexium. "The commission has reason to believe that the companies concerned may have acted individually or jointly, notably to delay generic entry for a particular medicine," said an EU ...
-
-
Shares in the Anglo-Swedish giant dropped 11.5p to 3,053p after it emerged that the investigation centres on its best-selling heartburn pill Nexium. The Commission said it Ohas reason to believe that the companies concerned may have acted individually or ...
-
-
Now I can't be off it for one day without wanting to die. People who take powerful acid-suppressing drugs such as omeprazole (Prilosec), lansoprazole (Prevacid) and esomeprazole (Nexium) often have difficulties with rebound acidity if they stop suddenly.
-
-
Astra is winding down its U.S. sales force for heartburn pill Nexium , turning instead to call centers and online information. Online sampling of Nexium is expected to be available by the end of the year, DJN says.
-
-
BRUSSELS, Dec 3 (Reuters) - AstraZeneca ( AZN.L ), which makes the best-selling heartburn drug Nexium, has been raided by EU antitrust regulators investigating suspected collusion to block the sale of cheaper generic medicines. Company officials said the $ ...
-
-
The U.S. Food and Drug Administration (FDA) approved VIMOVO™ (naproxen and esomeprazole magnesium) (see About VIMOVO), and POZEN transferred ownership of the U.S. regulatory filings to AstraZeneca. POZEN ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
Pages:
1
2
3
Next
|
|
